{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:51:49Z","timestamp":1791809509769,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cancer Policy"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jcpo.2026.100805","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:57:48Z","timestamp":1788620268000},"page":"100805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Beyond single age, single gender: Strengthening India's human papilloma virus (HPV) vaccination strategy"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6902-5845","authenticated-orcid":false,"given":"Kinshuk","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2117-4195","authenticated-orcid":false,"given":"Aninda","family":"Debnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10224","key":"10.1016\/j.jcpo.2026.100805_bib1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","article-title":"Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Brisson","year":"2020","journal-title":"Lancet"},{"issue":"10224","key":"10.1016\/j.jcpo.2026.100805_bib2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(20)30157-4","article-title":"Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Canfell","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jcpo.2026.100805_bib3","series-title":"Prime Minister to Launch Nationwide HPV Vaccination Drive for 14-year-old Girls from Ajmer Tomorrow [Internet]","author":"Ministry of Health and Family Welfare (IN)","year":"2026"},{"key":"10.1016\/j.jcpo.2026.100805_bib4","article-title":"Unveiling the cancer epidemic in India: a glimpse into GLOBOCAN 2022 and past patterns","volume":"34","author":"Singh","year":"2025","journal-title":"Lancet Reg. Health Southeast. Asia"},{"issue":"3","key":"10.1016\/j.jcpo.2026.100805_bib5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.4103\/ijc.ijc_26_23","article-title":"Introduction of HPV vaccine in universal immunization programme of India","volume":"61","author":"Bashar","year":"2024","journal-title":"Indian J. Cancer"},{"key":"10.1016\/j.jcpo.2026.100805_bib6","series-title":"SAGE Evidence to Recommendations Framework: Human Papillomavirus (HPV) Vaccine Choice [Internet]","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.jcpo.2026.100805_bib7","unstructured":"Gavi, The Vaccine Alliance. Human papillomavirus vaccine support [Internet], Gavi, Geneva, [cited 2026 Aug 7]. Available from: https:\/\/www.gavi.org\/types-support\/vaccine-support\/human-papillomavirus."},{"key":"10.1016\/j.jcpo.2026.100805_bib8","doi-asserted-by":"crossref","first-page":"e2153","DOI":"10.1016\/S2214-109X(25)00376-6","article-title":"Ranking the most efficient human papillomavirus vaccination strategies in low-income and lower-middle income countries: a mathematical modelling analysis","volume":"13","author":"B\u00e9nard","year":"2025","journal-title":"Lancet Glob. Health"},{"issue":"1","key":"10.1016\/j.jcpo.2026.100805_bib9","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2480870","article-title":"Human papillomavirus vaccination at age 9 or 10 years to increase coverage: a narrative review of the literature, United States, 2014\u20132024","volume":"21","author":"Brewer","year":"2025","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jcpo.2026.100805_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1067299","article-title":"Gender neutral HPV vaccination programs: reconsidering policies to expand cancer prevention globally","volume":"11","author":"Dykens","year":"2023","journal-title":"Front. Public Health"},{"key":"10.1016\/j.jcpo.2026.100805_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2020.552028","article-title":"Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation","volume":"8","author":"Kombe","year":"2021","journal-title":"Front. Public Health"},{"issue":"5","key":"10.1016\/j.jcpo.2026.100805_bib12","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/ajco.14181","article-title":"Systematic literature review on the burden of human papillomavirus infection and related diseases in India","volume":"21","author":"De","year":"2025","journal-title":"Asia Pac. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.jcpo.2026.100805_bib13","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","article-title":"HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management","volume":"19","author":"Lechner","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jcpo.2026.100805_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106399","article-title":"HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010\u20132019","volume":"144","author":"Bruni","year":"2021","journal-title":"Prev. Med."},{"key":"10.1016\/j.jcpo.2026.100805_bib15","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.vaccine.2018.03.024","article-title":"Systematic review of cost-effectiveness studies of human papillomavirus (HPV) vaccination: 9-valent vaccine, gender-neutral and multiple age cohort vaccination","volume":"36","author":"Ng","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jcpo.2026.100805_bib16","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.85735","article-title":"Building resilient cervical cancer prevention through gender-neutral HPV vaccination","volume":"12","author":"Man","year":"2023","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.jcpo.2026.100805_bib17","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2514949","article-title":"Impact of HPV vaccination on hospitalizations for anogenital warts and high-grade cervical intraepithelial neoplasia in Brazil","volume":"21","author":"Bierrenbach","year":"2025","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jcpo.2026.100805_bib18","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1186\/s12889-026-26730-9","article-title":"Perceptions of a gender-neutral approach to human papillomavirus (HPV) vaccination in Cameroon: a qualitative study","volume":"26","author":"Iliassu","year":"2026","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jcpo.2026.100805_bib19","article-title":"Centre's HPV vaccine rollout opens \u20b91300 crore annual procurement market [Internet]","author":"Sharma","year":"2026","journal-title":"Bus. Today"},{"issue":"11","key":"10.1016\/j.jcpo.2026.100805_bib20","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S1470-2045(21)00453-8","article-title":"Vaccine efficacy against persistent human papillomavirus (HPV) 16\/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India","volume":"22","author":"Basu","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcpo.2026.100805_bib21","unstructured":"International Agency for Research on Cancer, A randomized, active-controlled, assessor-blind trial to establish non-inferiority of immunogenicity of a single dose of CERVAVAC quadrivalent HPV vaccine compared to the Gardasil quadrivalent vaccine among girls and boys aged 9\u201314 years and in girls\/women aged 15\u201320 years in Zambia [Internet], ClinicalTrials.gov. National Library of Medicine (US), Bethesda (MD), 2025 [cited 2026 Aug 7]. Identifier: NCT07256912. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07256912."},{"key":"10.1016\/j.jcpo.2026.100805_bib22","unstructured":"Bhuyan A., A locally-made HPV vaccine in India faces hesitancy and delays [Internet], Undark Magazine, 2023 [cited 2026 Aug 7]. Available from: https:\/\/undark.org\/2023\/09\/13\/a-locally-made-hpv-vaccine-in-india-faces-hesitancy-and-delays\/."},{"issue":"6","key":"10.1016\/j.jcpo.2026.100805_bib23","doi-asserted-by":"crossref","first-page":"743","DOI":"10.25259\/IJMR_1834_2025","article-title":"Barriers to HPV vaccination among adolescent girls in India: a scoping review","volume":"162","author":"Josten","year":"2026","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.jcpo.2026.100805_bib24","series-title":"Final Report of the Committee Appointed by the Government of India to Examine the Circumstances Relating to the Deaths in the HPV Demonstration Project [Internet]","author":"Indian Council of Medical Research","year":"2011"},{"issue":"1","key":"10.1016\/j.jcpo.2026.100805_bib25","doi-asserted-by":"crossref","first-page":"A17","DOI":"10.1016\/j.vaccine.2021.07.024","article-title":"Human papillomavirus (HPV) vaccine introduction in Sikkim state","volume":"40","author":"Ahmed","year":"2022","journal-title":"Vaccine"}],"container-title":["Journal of Cancer Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213538326001062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213538326001062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:43:22Z","timestamp":1791809002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213538326001062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":25,"alternative-id":["S2213538326001062"],"URL":"https:\/\/doi.org\/10.1016\/j.jcpo.2026.100805","relation":{},"ISSN":["2213-5383"],"issn-type":[{"value":"2213-5383","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond single age, single gender: Strengthening India's human papilloma virus (HPV) vaccination strategy","name":"articletitle","label":"Article Title"},{"value":"Journal of Cancer Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcpo.2026.100805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100805"}}